Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults

NCT01139190 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroduodenal Ulcerations
Erosion

Interventions

DRUG: PL3100
DRUG: Naproxen

Sponsor

PLx Pharma

Collaborators

[object Object]